![](/img/cover-not-exists.png)
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn’s disease
Ma, Christophers, Jairath, Vipul, Khanna, Reena, Feagan, Brian G.Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2018.1506764
Date:
July, 2018
File:
PDF, 1.33 MB
english, 2018